Delivery Order SPE2DB22D1106-SPE2DB25FFHV3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,808.85 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, falls within the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. Valued at $1,512.09 under a firm fixed-price arrangement, this non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The contract is fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,436.56 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) on July 28, 2025. This firm fixed-price delivery order, designated as contract 4568902309, is scheduled for completion by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100 units, with a ceiling value of $1,417.13 and an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.28 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on July 24, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by July 25, 2025, with work to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Premarin is a conjugated estrogen hormone replacement therapy...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $44,883.40 firm fixed-price delivery order on August 20, 2025, for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. The contract is non-set-aside and represents a competitively awarded delivery order with an ultimate completion date of August 21, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,385.11 to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. This non-set-aside contract was competitively awarded with a firm fixed price structure and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,614.48 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Premarin 0.625 mg tablets (100-count units) with a contract ceiling value of $1,490.37. This firm fixed-price delivery order, which is expected to be completed by August 4, 2025, represents a non-competitive set-aside arrangement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,251.80 to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified vendors. This delivery order is...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHV3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,347.03 to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count packages) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to military and veteran healthcare systems through the Defense Health Agency and other government healthcare customers. The company's significant IDC capacity and demonstrated track record of fulfilling diverse pharmaceutical requirements across multiple therapeutic domains position it as a primary supplier for federal medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/9/25 |